Exact Mass: 458.227757
Exact Mass Matches: 458.227757
Found 500 metabolites which its exact mass value is equals to given mass value 458.227757
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Astemizole
C28H31FN4O (458.24817679999995)
Astemizole is a long-acting, non-sedating second generation antihistamine used in the treatment of allergy symptoms. It was withdrawn from market by the manufacturer in 1999 due to the potential to cause arrhythmias at high doses, especially when when taken with CYP inhibitors or grapefruit juice. R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents Astemizole (R 43512), a second-generation antihistamine agent to diminish allergic symptoms with a long duration of action, is a histamine H1-receptor antagonist, with an IC50 of 4 nM. Astemizole also shows potent hERG K+ channel blocking activity with an IC50 of 0.9 nM. Astemizole has antipruritic effects[1][2].
fumagillin
A meroterpenoid resulting from the formal condensation of the hydroxy group of fumagillol with the carboxylic acid group of (all-E)-deca-2,4,6,8-tetraenedioic acid. Originally isolated from the fungus Aspergillus fumigatus, it is used for the control of Nosema infection in honey bees. P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D006133 - Growth Substances > D006131 - Growth Inhibitors Fumagillin(NSC9168) is an antimicrobial compound first isolated in 1949 from the fungus Aspergillus fumigatu. Fumagillin can inhibits HIV‐1 infection through the inhibition of HIV-1 viral protein R (Vpr) activity.
Cinobufotalin
Cinobufotalin is a natural product found in Bufo and Bufo bufo with data available. Cinobufotalin is a bufadienolide isolated from toad venom and utilized in traditional Chinese medicine (TCM) for its cardiotonic, diuretic and hemostatic effects, with potential cytotoxic and antineoplastic activities. Upon administration and although the exact mechanism of action(s) (MoAs) through which this agent exerts its effects have yet to be fully discovered, cinobufotalin causes DNA fragmentation, decreases mitochondrial membrane potential (MMP), increases intracellular calcium (Ca2+) ion concentrations and reactive oxygen species (ROS) production, upregulates Fas protein and activates cytochrome C, various caspases, Bid and Bax. This causes cell cycle arrest, induces apoptosis and inhibits tumor cell growth and survival. In addition, cinobufotalin inhibits the activity of sphingosine kinase 1 (SphK1) and induces pro-apoptotic ceramide production, which further promotes tumor cell apoptosis. Cinobufotalin also induces mitochondrial protein cyclophilin D (Cyp-D)-dependent opening of the mitochondrial permeability transition pore (mPTP), which may contribute to cinobufotalin-induced non-apoptotic death of certain tumor cells. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides Cinobufotalin is a cardiotonic steroids or bufadienolides, is extracted from the skin secretions of the giant toads. Cinobufotalin has been used as a cardiotonic, diuretic and a hemostatic agent, Cinobufotalin is also a potential anti-lung cancer agent[1].
3-Sulfodeoxycholic acid
Deoxycholic Acid/analogs and derivatives.
1-Lyso-2-arachidonoyl-phosphatidate
LPA(0:0/20:4n6) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells.LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293) [HMDB] LPA(0:0/20:4n6) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells.LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293).
Hydroxystrobilurin D
Hydroxystrobilurin D is found in mushrooms. Hydroxystrobilurin D is isolated from Mycena sanguinolenta (blood mycena Isolated from Mycena sanguinolenta (blood mycena). Hydroxystrobilurin D is found in mushrooms.
LysoPA(20:4(5Z,8Z,11Z,14Z)/0:0)
1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphate is also known as LPA(20:4(5Z,8Z,11Z,14Z)/0:0) or 1-Arachidonoyl lpa. 1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphate is a glycerophosphate lipid molecule
LysoPA(20:4(8Z,11Z,14Z,17Z)/0:0)
LysoPA(20:4(8Z,11Z,14Z,17Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(20:4(8Z,11Z,14Z,17Z)/0:0), in particular, consists of one chain of eicosatetraenoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
fumagillin
2-Hydroxy-3-[(2-carboxyethyl)thio]-3-[2-(8-phenyloctyl)phenyl]propanoic acid
C26H34O5S (458.21268340000006)
D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D020024 - Leukotriene Antagonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists
Avitriptan
C22H30N6O3S (458.20999900000004)
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist
Cinobufotalin
Cinobufotalin is a cardiotonic steroids or bufadienolides, is extracted from the skin secretions of the giant toads. Cinobufotalin has been used as a cardiotonic, diuretic and a hemostatic agent, Cinobufotalin is also a potential anti-lung cancer agent[1].
(E)-8-(2-(4-(Diphenylamino)benzylidene)hydrazinyl)-N-hydroxy-8-oxooctanamide
C27H30N4O3 (458.23177899999996)
3-Prenylrubranine
Sophoranochromene
Sophoradochromene
2-methyl-5-(1-methylethyl)-phenyl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside|carvacrol 2-O-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside
(5S)--5,6,7,7a,7b,12b-hexahydro-3,4,5,11,12b-pentamethyl-10-[(3E)-pent-3-en-1-yl]-furo[3,2:6,7]naphthol[1,8:4,5,6]pyrano[3,2-b]benzofuran-9-ol
3alpha,11alpha-cyclotaxinine NN-2|3alpha,9alpha,10beta-triacetoxy-3alpha,11alpha-cyclotaxa-4(20),5-dien-13-one
(2E)-1-(3,4-dihydro-5-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-yl)-3-[2,2-dimethyl-8-(3-methylbut-2-enyl)-2H-1-benzopyran-6-yl]prop-2-en-1-one|tokinochromane C
6beta,9beta-diacetoxy-1alpha-benzoyloxydihydro-beta-agarofuran
5-Hydroxy-8-(4-methyl-3-pentenyl)-8-methyl-6-(2-methyl-1-oxopropyl)-4-phenyl-2H,8H-benzo[1,2-b:3,4-b]dipyran-2-one
(1alpha,4beta,8beta)-6-Chloro-1,4,8,15-tetrahydroxy-6-hirsuten-5-one|chloriolin B
C23H35ClO7 (458.20711900000003)
4,6-decadiyne-1-O-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside
berkeleyone B
A meroterpenoid found in Penicillium rubrum and has been shown to exhibit inhibitory activity against caspase-1.
berkeleyone C
A meroterpenoid found in Penicillium rubrum and has been shown to exhibit inhibitory activity against caspase-1.
Hydroxystrobilurin D
9-acetoxy-gamma-geraniol-(2,6-diacetyl-beta-D-glucopyranoside)
1alpha,8beta-diacetoxy-9beta-benzoyloxydihydro-beta-agarofuran
lespeflorin A3
A monohydroxyflavanone that is flavanone substituted with a hydroxy group at position 7, prenyl groups at positions 6 and 8 and a 6,6-dimethyl-3,6-dihydro-2H-pyran ring fused across positions 3 and 4. Isolated from the roots of Lespedeza floribunda, it acts as a melanin synthesis inhibitor.
23-Methylauricepyron|23-Methylauricepyrone|Methylauricepyron
1alpha,15-diacetoxy-9beta-benzoyloxy-beta-dihydrofuran
C26H34O7_1,1,5a,7a,9,11b-Hexamethyl-7-methylene-3,8,11-trioxo-3,5a,5b,6,7,7a,8,9,11,11a,11b,12,13,13a-tetradecahydro-1H-isochromeno[7,8-g][2]benzoxepin-12-yl acetate
C26H34O7_8,12-Methanocycloocta[3,4]benz[1,2-c]oxepin-8(5H)-carboxylic acid, 3,5a,6,7,7a,9,10,11,12,13,13a,13b-dodecahydro-10-hydroxy-5,5,7a,10,12,13b-hexamethyl-14-methylene-3,9,11-trioxo-, methyl ester
2,7,7,11,15,17-hexamethyl-18-methylidene-5,13,16-trioxo-6,14-dioxatetracyclo[9.8.0.0²,⁸.0¹²,¹⁷]nonadec-3-en-10-yl acetate
2,7,7,11,15,17-hexamethyl-18-methylidene-5,13,16-trioxo-6,14-dioxatetracyclo[9.8.0.0²,⁸.0¹²,¹⁷]nonadec-3-en-10-yl acetate_major
2,7,7,11,15,17-hexamethyl-18-methylidene-5,13,16-trioxo-6,14-dioxatetracyclo[9.8.0.0²,?.0¹²,¹?]nonadec-3-en-10-yl acetate
Ala Leu Gln Gln
Glu Ile Pro Thr
Glu Ile Thr Pro
Glu Leu Pro Thr
Glu Leu Thr Pro
Glu Pro Ile Thr
Glu Pro Leu Thr
Glu Pro Thr Ile
Glu Pro Thr Leu
Glu Thr Ile Pro
Glu Thr Leu Pro
Glu Thr Pro Ile
Glu Thr Pro Leu
Phe Gly His Val
Phe Gly Val His
Phe His Gly Val
Phe His Val Gly
Phe Val Gly His
Phe Val His Gly
Gly Phe His Val
Gly Phe Val His
Gly His Phe Val
Gly His Val Phe
Gly Val Phe His
Gly Val His Phe
His Phe Gly Val
His Phe Val Gly
His Gly Phe Val
His Gly Val Phe
His Thr Thr Thr
His Val Phe Gly
His Val Gly Phe
Ile Glu Pro Thr
Ile Glu Thr Pro
Ile Pro Glu Thr
Ile Pro Thr Glu
Ile Thr Glu Pro
Ile Thr Pro Glu
Leu Glu Pro Thr
Leu Glu Thr Pro
Leu Pro Glu Thr
Leu Pro Thr Glu
Leu Thr Glu Pro
Leu Thr Pro Glu
Asn Ile Asn Val
Asn Ile Val Asn
Asn Lys Pro Thr
Asn Lys Thr Pro
Asn Leu Asn Val
Asn Leu Val Asn
Asn Asn Ile Val
Asn Asn Leu Val
Asn Asn Val Ile
Asn Asn Val Leu
Asn Pro Lys Thr
Asn Pro Gln Thr
Asn Pro Thr Lys
Asn Pro Thr Gln
Asn Gln Pro Thr
Asn Gln Thr Pro
Asn Gln Val Val
Asn Thr Lys Pro
Asn Thr Pro Lys
Asn Thr Pro Gln
Asn Thr Gln Pro
Asn Val Ile Asn
Asn Val Leu Asn
Asn Val Asn Ile
Pro Glu Ile Thr
Pro Glu Leu Thr
Pro Glu Thr Ile
Pro Glu Thr Leu
Pro Ile Glu Thr
Pro Ile Thr Glu
Pro Leu Glu Thr
Pro Leu Thr Glu
Pro Asn Gln Thr
Pro Asn Thr Gln
Pro Gln Asn Thr
Pro Gln Gln Ser
Pro Gln Ser Gln
Pro Gln Thr Asn
Pro Ser Lys Gln
Pro Ser Gln Lys
Pro Ser Gln Gln
Pro Thr Glu Ile
Pro Thr Glu Leu
Pro Thr Ile Glu
Pro Thr Leu Glu
Pro Thr Asn Lys
Pro Thr Asn Gln
Pro Thr Gln Asn
Gln Ala Ile Gln
Gln Ala Leu Gln
Gln Ala Gln Ile
Gln Ala Gln Leu
Gln Ile Ala Gln
Gln Ile Gln Ala
Gln Lys Pro Ser
Gln Asn Pro Thr
Gln Asn Thr Pro
Gln Pro Asn Thr
Gln Pro Gln Ser
Gln Pro Ser Lys
Gln Pro Ser Gln
Gln Pro Thr Asn
Gln Gln Ala Ile
Gln Gln Ala Leu
Gln Gln Ile Ala
Gln Gln Leu Ala
Gln Gln Pro Ser
Gln Gln Ser Pro
Gln Ser Lys Pro
Gln Ser Pro Lys
Gln Ser Pro Gln
Gln Ser Gln Pro
Gln Thr Asn Pro
Gln Thr Pro Asn
Gln Val Asn Val
Gln Val Val Asn
Ser Lys Pro Gln
Ser Lys Gln Pro
Ser Pro Lys Gln
Ser Pro Gln Lys
Ser Pro Gln Gln
Ser Gln Lys Pro
Ser Gln Pro Lys
Ser Gln Pro Gln
Ser Gln Gln Pro
Thr Glu Ile Pro
Thr Glu Leu Pro
Thr Glu Pro Ile
Thr Glu Pro Leu
Thr His Thr Thr
Thr Ile Glu Pro
Thr Ile Pro Glu
Thr Lys Asn Pro
Thr Lys Pro Asn
Thr Leu Glu Pro
Thr Leu Pro Glu
Thr Asn Lys Pro
Thr Asn Pro Lys
Thr Asn Pro Gln
Thr Asn Gln Pro
Thr Pro Glu Ile
Thr Pro Glu Leu
Thr Pro Ile Glu
Thr Pro Lys Asn
Thr Pro Leu Glu
Thr Pro Asn Lys
Thr Pro Asn Gln
Thr Pro Gln Asn
Thr Gln Asn Pro
Thr Gln Pro Asn
Thr Thr His Thr
Thr Thr Thr His
Val Phe Gly His
Val Phe His Gly
Val Gly Phe His
Val Gly His Phe
Val His Phe Gly
Val His Gly Phe
Val Ile Asn Asn
Val Leu Asn Asn
Val Asn Ile Asn
Val Asn Leu Asn
Val Asn Asn Ile
Val Asn Asn Leu
Val Asn Gln Val
Val Asn Val Gln
Val Gln Asn Val
Val Gln Val Asn
Val Val Asn Gln
Val Val Gln Asn
LysoPA(20:4/0:0)
17-trifluoromethylphenyl-13,14-dihydro trinor PGF2&alpha
C24H33F3O5 (458.22799640000005)
4-((1H-INDAZOL-6-YL)AMINO)-6-METHOXY-7-(3-MORPHOLINOPROPOXY)QUINOLINE-3-CARBONITRILE
C25H26N6O3 (458.20662860000004)
decanedioic acid,dimethyl benzene-1,4-dicarboxylate,ethane-1,2-diol
3-Pyridinecarbonitrile, 1,2-dihydro-6-hydroxy-4-methyl-1-3-(1-methylethoxy)propyl-2-oxo-5-4-(phenylazo)phenylazo-
C25H26N6O3 (458.20662860000004)
1-oleoyl-sn-glycero-3-phosphate sodium salt
C21H40NaO7P (458.24092200000007)
1-(4-Phenylboronic acid pinacol ester)-1,2,2-triphenylethene
C32H31BO2 (458.24169759999995)
5-[(1R)-1-Hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-8-(phenylmethoxy)-2(1H)-quinolinone
2-C-(2,3,4,6-Tetra-O-benzyl-a-D-glucopyranosyl) ethyne
2-(1-((2-(1H-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)Methyl)-2-butyl-4-Methyl-6-oxo-1,6-dihydropyriMidin-5-yl)acetic acid
C25H26N6O3 (458.20662860000004)
4-(8-((4-((1S,4S)-5-Isopropyl-2,5-diazabicyclo(2.2.1)heptan-2-yl)phenyl)amino)-(1,2,4)triazolo(1,5-a)pyrazin-5-yl)furan-2-carboxamide
N-hydroxy-N-[(E)-[4-(N-phenylanilino)phenyl]methylideneamino]octanediamide
C27H30N4O3 (458.23177899999996)
D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors D000970 - Antineoplastic Agents
Ethyl 4-[[7-[(4-fluorophenyl)methyl]-1,3-dimethyl-2,6-dioxopurin-8-yl]methyl]piperazine-1-carboxylate
3-[(3-Aminomethyl-biphenyl-4-carbonyl)-amino]-2-(3-carbamimidoyl-benzyl)-butyric acid methyl ester
C27H30N4O3 (458.23177899999996)
4-(4-Hydroxy-2-methoxy-6-pentylbenzoyl)oxy-2-methoxy-6-pentylbenzoic acid
(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E)-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenedioate
C30H34O4-2 (458.24569640000004)
[(1S,2R,3R,4S,5R)-5-azaniumyl-2-[(2S,3R,4R,5S,6R)-3-azaniumyl-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4-hydroxycyclohexyl]azanium
2-amino-N-[5-[(6-dimethylamino-9H-purin-9-yl)]-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl]-3-(4-hydroxyphenyl)-propanamid
C21H28N7O5+ (458.21518180000004)
Fumagilina
Fumagillin(NSC9168) is an antimicrobial compound first isolated in 1949 from the fungus Aspergillus fumigatu. Fumagillin can inhibits HIV‐1 infection through the inhibition of HIV-1 viral protein R (Vpr) activity.
Berkeleytrione
A meroterpenoid found in Penicillium rubrum and has been shown to exhibit inhibitory activity against caspase-1.
Homoplatensimide A
A polycyclic cage compound isolated from Streptomyces platensis.
O-demethylpuromycin(1+)
C21H28N7O5+ (458.21518180000004)
The conjugate acid of O-demethylpuromycin; major species at pH 7.3.
3-[(2-methoxyphenyl)methyl]-5-[1-[(4-methylphenyl)-oxomethyl]-4-piperidinyl]-2H-triazolo[4,5-d]pyrimidin-7-one
C25H26N6O3 (458.20662860000004)
3-[[cyclopentyl-[[1-[(4-methoxyphenyl)methyl]-5-tetrazolyl]methyl]amino]methyl]-7-methyl-1H-quinolin-2-one
C26H30N6O2 (458.24301199999996)
3-[3,4-dihydro-1H-isoquinolin-2-yl-[1-(2-methylbutan-2-yl)-5-tetrazolyl]methyl]-7-methoxy-1H-quinolin-2-one
C26H30N6O2 (458.24301199999996)
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
N-[[(2R,4S,5R)-5-[2-methyl-6-[4-(triluoromethyl)phenyl]pyrimidin-4-yl]-1-azabicyclo[2.2.2]octan-2-yl]methyl]cyclobutanecarboxamide
1-(3-fluorophenyl)-3-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-fluorophenyl)-3-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-(2-oxo-2-piperidin-1-ylethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]oxane-4-carboxamide
1-(3-fluorophenyl)-3-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-fluorophenyl)-3-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-(2-oxo-2-piperidin-1-ylethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]oxane-4-carboxamide
1-(3-fluorophenyl)-3-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
(6R,7S,8S)-8-(hydroxymethyl)-4-[4-oxanyl(oxo)methyl]-7-[4-(3-phenylprop-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8S)-8-(hydroxymethyl)-4-[4-oxanyl(oxo)methyl]-7-[4-(3-phenylprop-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8S)-8-(hydroxymethyl)-4-[4-oxanyl(oxo)methyl]-7-[4-(3-phenylprop-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
1-(3-fluorophenyl)-3-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-fluorophenyl)-3-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
(6R,7R,8R)-8-(hydroxymethyl)-4-[4-oxanyl(oxo)methyl]-7-[4-(3-phenylprop-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8R)-8-(hydroxymethyl)-4-[4-oxanyl(oxo)methyl]-7-[4-(3-phenylprop-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-8-(hydroxymethyl)-4-[4-oxanyl(oxo)methyl]-7-[4-(3-phenylprop-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8S)-8-(hydroxymethyl)-4-[4-oxanyl(oxo)methyl]-7-[4-(3-phenylprop-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8R)-8-(hydroxymethyl)-4-[4-oxanyl(oxo)methyl]-7-[4-(3-phenylprop-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
L-alanyl-L-phenylalanyl-L-proline 2-naphthylamide
C27H30N4O3 (458.23177899999996)
6-hydroxy-6-(hydroxymethyl)-1,1,4a-trimethyl-5-{[(2-oxo-2H-chromen-7-yl)oxy]methyl}-decahydronaphthalen-2-yl acetate
6,8a-dihydroxy-1,1,4a,6-tetramethyl-5-{[(2-oxo-2H-chromen-7-yl)oxy]methyl}-decahydronaphthalen-2-yl acetate
6,7-dihydroxy-1,1,4a,6-tetramethyl-5-{[(2-oxo-2H-chromen-7-yl)oxy]methyl}-decahydronaphthalen-2-yl acetate
(1-phosphonooxy-3-propanoyloxypropan-2-yl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
astemizole
C28H31FN4O (458.24817679999995)
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents Astemizole (R 43512), a second-generation antihistamine agent to diminish allergic symptoms with a long duration of action, is a histamine H1-receptor antagonist, with an IC50 of 4 nM. Astemizole also shows potent hERG K+ channel blocking activity with an IC50 of 0.9 nM. Astemizole has antipruritic effects[1][2].
CID 14203
Cinobufotalin is a cardiotonic steroids or bufadienolides, is extracted from the skin secretions of the giant toads. Cinobufotalin has been used as a cardiotonic, diuretic and a hemostatic agent, Cinobufotalin is also a potential anti-lung cancer agent[1].
1-arachidonoyl-sn-glycerol 3-phosphate
A 1-acyl-sn-glycerol 3-phosphate in which the 1-O-acyl group is specified as arachidonoyl.
4,4-diapolycopenedioate
A dicarboxylic acid dianion derived from 4,4-diapolycopen-4,4-dioic acid. Major structure at pH 7.3,
2-Arachidonoyl-sn-glycero-3-phosphate
A 2-acyl-sn-glycerol 3-phosphate in which the phosphatidyl acyl group is specified as arachidonoyl.
Avitriptan
C22H30N6O3S (458.20999900000004)
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist
methyl (2Z,3E,5Z)-6-[4,4-dimethyl-3-(3-methylbut-2-enoxy)-2,3-dihydro-1,5-benzodioxepin-7-yl]-3-(hydroxymethyl)-2-(methoxymethylidene)hexa-3,5-dienoate
BIX 02565
C26H30N6O2 (458.24301199999996)
BIX 02565 is a potent ribosomal S6 kinase 2 (RSK2) inhibitor with IC50 of 1.1 nM.
(1r,2r,4s,7s,8s,11r,12r,13r,16r)-7-(furan-3-yl)-13-(methoxymethyl)-1,8,12,15,15-pentamethyl-3,6,14-trioxapentacyclo[9.7.0.0²,⁴.0²,⁸.0¹²,¹⁶]octadecane-5,18-dione
1-[9-hydroxy-1,5-dimethyl-5-(4-methylpent-3-en-1-yl)-6,15-dioxatetracyclo[9.3.1.0⁴,¹³.0⁷,¹²]pentadeca-7,9,11-trien-10-yl]-3-phenylprop-2-en-1-one
(4as,8as,9as)-9a-[(4as,8as,9as)-3,8a-dimethyl-5-methylidene-2-oxo-4h,4ah,6h,9h-naphtho[2,3-b]furan-9a-yl]-3,8a-dimethyl-5-methylidene-4h,4ah,6h,9h-naphtho[2,3-b]furan-2-one
3-{[2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-en-1-yl)-5-(2-methylbutanoyl)phenyl]methyl}-6-ethyl-4-hydroxy-5-methylpyran-2-one
2-[(5-{5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl}-1-hydroxy-2-methylpent-2-en-1-ylidene)amino]-4-(c-hydroxycarbonimidoyl)butanoic acid
2-({9-hydroxy-3,5-dimethyl-5h,6h,7h,8h-naphtho[2,3-b]furan-4-yl}methyl)-3,4,5-trimethyl-5h,6h,7h,8h-naphtho[2,3-b]furan-9-ol
(1s,2r,5s,6s,7s,9r,12r)-7,12-bis(acetyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl benzoate
methyl (2e,3z,5e)-6-(3-{[(2r)-3,3-dimethyloxiran-2-yl]methoxy}-4,4-dimethyl-2,3-dihydro-1,5-benzodioxepin-7-yl)-2-(methoxymethylidene)-3-methylhexa-3,5-dienoate
5-hydroxy-8-methyl-8-(4-methylpent-3-en-1-yl)-6-(2-methylpropanoyl)-4-phenylpyrano[2,3-f]chromen-2-one
(2e)-3-[2,2-dimethyl-8-(3-methylbut-2-en-1-yl)chromen-6-yl]-1-(5-hydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl)prop-2-en-1-one
(3r,8ar)-5-methyl-3-[(13-oxohexadecyl)oxy]-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
(8r)-5-hydroxy-8-methyl-8-(4-methylpent-3-en-1-yl)-6-(2-methylpropanoyl)-4-phenylpyrano[2,3-f]chromen-2-one
(2z,6e)-2-[(3r)-3-chloro-4-methylpent-4-en-1-yl]-9-[(2r)-6-hydroxy-2,8-dimethylchromen-2-yl]-6-methylnona-2,6-dienoic acid
C27H35ClO4 (458.22237400000006)
methyl 3-[7-hydroxy-11-methoxy-4,5a,9-trimethyl-1-oxo-8-(prop-1-en-2-yl)-3h,6h,7h,8h,9ah,10h-furo[3,4-b]xanthen-9-yl]propanoate
6-ethylidene-3,5,9-trihydroxy-8-isopropyl-11,20-dimethyl-4-oxa-11,20-diazapentacyclo[8.7.3.0¹,¹⁰.0²,⁷.0¹²,¹⁷]icosa-12,14,16-triene-2-carboxylic acid
2-(deca-4,6-diyn-1-yloxy)-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxane-3,4,5-triol
(2r,3r,4s,5s,6r)-2-(deca-4,6-diyn-1-yloxy)-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxane-3,4,5-triol
[(1r,4s,10s,11s,13s,15r)-11-(acetyloxy)-4-ethenyl-8,15-dihydroxy-4,10-dimethyl-7-oxotetracyclo[7.5.1.0¹,⁶.0¹³,¹⁵]pentadeca-5,8-dien-10-yl]methyl 2-methylpropanoate
12β-hydroxycinobufagin
{"Ingredient_id": "HBIN000753","Ingredient_name": "12\u03b2-hydroxycinobufagin","Alias": "NA","Ingredient_formula": "C26H34O7","Ingredient_Smile": "CC(=O)OC1C(C2(C(CC3C(C24C1O4)CCC5C3(CCC(C5)O)C)O)C)C6=COC(=O)C=C6","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9917","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1α,8β-diacetoxy-9β-benzoyloxydihydro-β-agarofuran
{"Ingredient_id": "HBIN002300","Ingredient_name": "1\u03b1,8\u03b2-diacetoxy-9\u03b2-benzoyloxydihydro-\u03b2-agarofuran","Alias": "NA","Ingredient_formula": "C26H34O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5285","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1-o-methylichangensin
{"Ingredient_id": "HBIN002923","Ingredient_name": "1-o-methylichangensin","Alias": "NA","Ingredient_formula": "C26H34O7","Ingredient_Smile": "CC1(C2CC(=O)C3(C(C2(C(O1)(C)OC)C)CCC4(C35C(O5)C(=O)OC4C6=COC=C6)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14516","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5-hydroxy-6-isobutyryl-8-methyl-8-(4-methyl-pent-3-enyl)-4-phenyl-2h-pyrano[2,3-h ]chro-men-2-one
{"Ingredient_id": "HBIN011628","Ingredient_name": "5-hydroxy-6-isobutyryl-8-methyl-8-(4-methyl-pent-3-enyl)-4-phenyl-2h-pyrano[2,3-h ]chro-men-2-one","Alias": "NA","Ingredient_formula": "C29H30O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10240","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6α-hydroxycinobufagin
{"Ingredient_id": "HBIN012203","Ingredient_name": "6\u03b1-hydroxycinobufagin","Alias": "NA","Ingredient_formula": "C26H34O7","Ingredient_Smile": "CC(=O)OC1C(C2(CCC3C(C24C1O4)CC(C5C3(CCC(C5)O)C)O)C)C6=COC(=O)C=C6","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9916","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
methyl 7-hydroxy-4,5,7,10,14,14-hexamethyl-6,8,17-trioxo-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadec-3-ene-9-carboxylate
3-{[2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-en-1-yl)-5-[(2r)-2-methylbutanoyl]phenyl]methyl}-6-ethyl-4-hydroxy-5-methylpyran-2-one
(2s)-2-[2,2-dimethyl-8-(3-methylbut-2-en-1-yl)chromen-6-yl]-7-hydroxy-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
[6-(furan-3-yl)-12,14-dihydroxy-7,9,11,15-tetramethyl-3,17-dioxapentacyclo[9.6.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁸]octadec-7-en-10-yl]acetic acid
methyl 3,4b,7,7,10a,12a-hexamethyl-12-methylidene-1,4,6,8-tetraoxo-hexahydro-3h-phenanthro[2,1-c]pyran-4a-carboxylate
2-[11-(2,6-dihydroxy-4-methoxyphenyl)-11-oxoundecyl]-3-hydroxyphenyl acetate
7,12-bis(acetyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl benzoate
9a-formyl-3a,5a-dihydroxy-11a-methyl-1-(6-oxopyran-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate
[(1r,3ar,3br,7s,9as,11ar)-3a,3b,7-trihydroxy-11a-methyl-1-(6-oxopyran-3-yl)-1h,2h,3h,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-9a-yl]methyl acetate
(1s,2r,10s,14r,24s)-10,12,14,20,22,24-hexamethyl-3,15,18-trioxaheptacyclo[14.10.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0¹⁷,²¹.0²³,²⁷]heptacosa-4(13),5,11,16,19,21,23(27)-heptaen-5-ol
6-ethylidene-5,9,13-trihydroxy-8-isopropyl-11,20-dimethyl-4-oxa-11,20-diazapentacyclo[8.7.3.0¹,¹⁰.0²,⁷.0¹²,¹⁷]icosa-12,14,16-triene-2-carboxylic acid
3-{1-[3-acetyl-2,4,6-trihydroxy-5-(3-methylbut-2-en-1-yl)phenyl]ethyl}-4-hydroxy-5-isopropyl-6-propylpyran-2-one
3-[2,2-dimethyl-8-(3-methylbut-2-en-1-yl)chromen-6-yl]-1-(5-hydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl)prop-2-en-1-one
(1s,7s,8z,12r,13s,14r)-14-(acetyloxy)-4,9,13,17-tetramethyl-5,15-dioxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-3,8,16-trien-12-yl 2-methylpropanoate
3-oxo-3-[(3,4,5-trihydroxy-6-{[4-(2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)butan-2-yl]oxy}oxan-2-yl)methoxy]propanoic acid
methyl 3-[(5as,7r,8s,9s,9ar)-7-hydroxy-11-methoxy-4,5a,9-trimethyl-1-oxo-8-(prop-1-en-2-yl)-3h,6h,7h,8h,9ah,10h-furo[3,4-b]xanthen-9-yl]propanoate
6-ethylidene-3,9,13-trihydroxy-8-isopropyl-11,20-dimethyl-4-oxa-11,20-diazapentacyclo[8.7.3.0¹,¹⁰.0²,⁷.0¹²,¹⁷]icosa-12,14,16-triene-2-carboxylic acid
9a-{3,8a-dimethyl-5-methylidene-2-oxo-4h,4ah,6h,9h-naphtho[2,3-b]furan-9a-yl}-3,8a-dimethyl-5-methylidene-4h,4ah,6h,9h-naphtho[2,3-b]furan-2-one
5-(acetyloxy)-6-[(acetyloxy)methyl]-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate
(2e,6e)-2-(3-chloro-4-methylpent-4-en-1-yl)-9-(6-hydroxy-2,8-dimethylchromen-2-yl)-6-methylnona-2,6-dienoic acid
C27H35ClO4 (458.22237400000006)
(2s)-2-{[(2e)-5-[(1s,5s,6s,7s,9s)-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl]-1-hydroxy-2-methylpent-2-en-1-ylidene]amino}-4-(c-hydroxycarbonimidoyl)butanoic acid
6,7-dihydroxy-2,2,9-trimethyl-12,12-bis(3-methylbut-2-en-1-yl)-1-oxatetracen-5-one
7-(furan-3-yl)-13-(methoxymethyl)-1,8,12,15,15-pentamethyl-3,6,14-trioxapentacyclo[9.7.0.0²,⁴.0²,⁸.0¹²,¹⁶]octadecane-5,18-dione
10,12,14,20,22,24-hexamethyl-3,15,18-trioxaheptacyclo[14.10.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0¹⁷,²¹.0²³,²⁷]heptacosa-4(13),5,11,16,19,21,23(27)-heptaen-5-ol
[11-(acetyloxy)-4-ethenyl-7-hydroxy-4,10-dimethyl-8-oxo-15-oxatetracyclo[7.6.1.0¹,⁶.0¹³,¹⁶]hexadeca-6,9(16)-dien-10-yl]methyl 2-methylpropanoate
(8ar)-5-methyl-3-[(14-oxohexadecyl)oxy]-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
(5s,6e,10e)-12-[2,5-dihydroxy-4-(2-methoxy-2-oxoethyl)phenyl]-2,6,10-trimethyl-4-oxododeca-2,6,10-trien-5-yl acetate
(1s,2r,5s,6e,7s,8r,9s,10s)-6-ethylidene-5,9,13-trihydroxy-8-isopropyl-11,20-dimethyl-4-oxa-11,20-diazapentacyclo[8.7.3.0¹,¹⁰.0²,⁷.0¹²,¹⁷]icosa-12,14,16-triene-2-carboxylic acid
4-{7-hydroxy-3,5-dimethyl-6-[(3e)-pent-3-en-1-yl]-1-benzofuran-4-yl}-3,5-dimethyl-6-[(3e)-pent-3-en-1-yl]-1-benzofuran-7-ol
4,5-bis(acetyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate
7-{3,4a,5-trimethyl-2-oxo-4h,5h,6h-naphtho[2,3-b]furan-9a-yl}-3,4a,5-trimethyl-4h,5h,6h,7h-naphtho[2,3-b]furan-2-one
(2s)-n-[(2r)-3-(acetyloxy)-2-benzylpropyl]-2-{[hydroxy(phenyl)methylidene]amino}-3-phenylpropanimidic acid
(6z)-6-ethylidene-5,9,13-trihydroxy-8-isopropyl-11,20-dimethyl-4-oxa-11,20-diazapentacyclo[8.7.3.0¹,¹⁰.0²,⁷.0¹²,¹⁷]icosa-12,14,16-triene-2-carboxylic acid
(3r,8ar)-5-methyl-3-[(14-oxohexadecyl)oxy]-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
methyl (2e,3e,5e)-6-(3-{[(2s)-3,3-dimethyloxiran-2-yl]methoxy}-4-[(3-methylbut-2-en-1-yl)oxy]phenyl)-3-(hydroxymethyl)-2-(methoxymethylidene)hexa-3,5-dienoate
methyl (2r,3as,3br,5ar,9ar,9br,11as)-2-hydroxy-2,3b,6,6,9a,11a-hexamethyl-11-methylidene-1,3,5,7-tetraoxo-hexahydrocyclopenta[a]phenanthrene-3a-carboxylate
(2r)-2-[2,2-dimethyl-8-(3-methylbut-2-en-1-yl)chromen-6-yl]-7-hydroxy-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
4-(2-hydroxy-4-methoxy-6-pentylbenzoyloxy)-2-methoxy-6-pentylbenzoic acid
methyl 3-hydroxy-2,7,7,11,14,17-hexamethyl-5,15-dioxo-6,12-dioxatetracyclo[9.9.0.0²,⁸.0¹³,¹⁹]icosa-13,16,18-triene-16-carboxylate
[11-(acetyloxy)-4-ethenyl-8,15-dihydroxy-4,10-dimethyl-7-oxotetracyclo[7.5.1.0¹,⁶.0¹³,¹⁵]pentadeca-5,8-dien-10-yl]methyl 2-methylpropanoate
(2e)-1-[(1r,4s,5r,13r)-9-hydroxy-1,5-dimethyl-5-(4-methylpent-3-en-1-yl)-6,15-dioxatetracyclo[9.3.1.0⁴,¹³.0⁷,¹²]pentadeca-7,9,11-trien-8-yl]-3-phenylprop-2-en-1-one
(1s,2r,5s,6s,7r,8s,9s)-5,8-bis(acetyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate
2-(3-chloro-4-methylpent-4-en-1-yl)-9-(6-hydroxy-2,8-dimethylchromen-2-yl)-6-methylnona-2,6-dienoic acid
C27H35ClO4 (458.22237400000006)
(1s,2r,6e,7s,8r,9s,10s)-6-ethylidene-9,13,16-trihydroxy-8-isopropyl-11,20-dimethyl-4-oxa-11,20-diazapentacyclo[8.7.3.0¹,¹⁰.0²,⁷.0¹²,¹⁷]icosa-12,14,16-triene-2-carboxylic acid
(2s,3r,4s,5s,6r)-2-(5-isopropyl-2-methylphenoxy)-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxane-3,4,5-triol
methyl 6-{4,4-dimethyl-3-[(3-methylbut-2-en-1-yl)oxy]-2,3-dihydro-1,5-benzodioxepin-7-yl}-2-(methoxymethylidene)-3-methyl-4-oxohex-5-enoate
methyl (1r,3s,3ar,8as)-1-(2-methoxy-2-oxoethyl)-3a-methyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3,4,5,8,8a-hexahydro-1h-azulene-6-carboxylate
(1r,2s,4r,5r,6r,7r,10s,11r,14s,16s)-14,16-dihydroxy-7,11-dimethyl-6-(6-oxopyran-3-yl)-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadecan-5-yl acetate
5,13,17,19-tetrahydroxy-22,22-dimethyl-7-pentylpentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1,3(12),4,6,8,13,16,18,20-nonaen-15-one
6-ethylidene-9,13,16-trihydroxy-8-isopropyl-11,20-dimethyl-4-oxa-11,20-diazapentacyclo[8.7.3.0¹,¹⁰.0²,⁷.0¹²,¹⁷]icosa-12,14,16-triene-2-carboxylic acid
2-{[(5r)-9-hydroxy-3,5-dimethyl-5h,6h,7h,8h-naphtho[2,3-b]furan-4-yl]methyl}-3,5-dimethyl-6-[(3e)-pent-3-en-1-yl]-1-benzofuran-7-ol
(6z)-6-ethylidene-9,13,16-trihydroxy-8-isopropyl-11,20-dimethyl-4-oxa-11,20-diazapentacyclo[8.7.3.0¹,¹⁰.0²,⁷.0¹²,¹⁷]icosa-12,14,16-triene-2-carboxylic acid
5-methyl-3-[(14-oxohexadecyl)oxy]-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
[(1r,2s,4r,6s,9r,10r,11r,12s,14r,15r,18r)-6-(furan-3-yl)-12,14-dihydroxy-7,9,11,15-tetramethyl-3,17-dioxapentacyclo[9.6.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁸]octadec-7-en-10-yl]acetic acid
3-{[2,4-dihydroxy-6-methoxy-5-(3-methylbut-2-en-1-yl)-3-(2-methylbutanoyl)phenyl]methyl}-6-ethyl-4-hydroxy-5-methylpyran-2-one
methyl (3s,4ar,4bs,6as,10as,10bs,12ar)-3,4b,7,7,10a,12a-hexamethyl-12-methylidene-1,4,6,8-tetraoxo-hexahydro-3h-phenanthro[2,1-c]pyran-4a-carboxylate
[(2r,3r,7r,9as,9bs,10ar)-2-(acetyloxy)-7-ethenyl-4,9a-dihydroxy-3,7-dimethyl-5-oxo-1h,2h,8h,9h,10h,10ah-cyclopropa[f]phenanthren-3-yl]methyl 2-methylpropanoate
(1r,2r,3r,4r,9r,10r,11r,14s)-2,10-bis(acetyloxy)-4,14,15,15-tetramethyl-8-methylidene-13-oxotetracyclo[9.3.1.0¹,⁹.0⁴,⁹]pentadec-6-en-3-yl acetate
(3r,8ar)-5-methyl-3-[(12-oxohexadecyl)oxy]-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
methyl 2-{4-[8-(acetyloxy)-3,7,11-trimethyl-9-oxododeca-2,6,10-trien-1-yl]-2,5-dihydroxyphenyl}acetate
2-({9-hydroxy-3,5-dimethyl-5h,6h,7h,8h-naphtho[2,3-b]furan-4-yl}methyl)-3,5-dimethyl-6-(pent-3-en-1-yl)-1-benzofuran-7-ol
(2z,6e)-2-(3-chloro-4-methylpent-4-en-1-yl)-9-(6-hydroxy-2,8-dimethylchromen-2-yl)-6-methylnona-2,6-dienoic acid
C27H35ClO4 (458.22237400000006)
(2e)-1-[(1r,4s,5r,13r)-9-hydroxy-1,5-dimethyl-5-(4-methylpent-3-en-1-yl)-6,15-dioxatetracyclo[9.3.1.0⁴,¹³.0⁷,¹²]pentadeca-7,9,11-trien-10-yl]-3-phenylprop-2-en-1-one
methyl (1r,2s,11s,12s,14s,16s)-16-hydroxy-2,6,6,11,14,16-hexamethyl-18-methylidene-8,15,17-trioxo-7-oxatetracyclo[12.3.1.0²,¹².0⁵,¹¹]octadec-4-ene-1-carboxylate
3-oxo-3-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2r)-4-[(1s)-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl]butan-2-yl]oxy}oxan-2-yl]methoxy}propanoic acid
3-(8-hydroxyocta-1,6-dien-1-yl)-4-[2-(4-methyl-2,5-dioxofuran-3-yl)nonyl]furan-2,5-dione
(6e)-6-ethylidene-3,9,13-trihydroxy-8-isopropyl-11,20-dimethyl-4-oxa-11,20-diazapentacyclo[8.7.3.0¹,¹⁰.0²,⁷.0¹²,¹⁷]icosa-12,14,16-triene-2-carboxylic acid
5-methyl-3-[(13-oxohexadecyl)oxy]-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
(6z)-6-ethylidene-3,5,9-trihydroxy-8-isopropyl-11,20-dimethyl-4-oxa-11,20-diazapentacyclo[8.7.3.0¹,¹⁰.0²,⁷.0¹²,¹⁷]icosa-12,14,16-triene-2-carboxylic acid
(1s,2r,10s,14s,24s)-10,12,14,20,22,24-hexamethyl-3,15,18-trioxaheptacyclo[14.10.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0¹⁷,²¹.0²³,²⁷]heptacosa-4(13),5,11,16,19,21,23(27)-heptaen-5-ol
methyl (1s,2s,3r,8r,11s)-3-hydroxy-2,7,7,11,14,17-hexamethyl-5,15-dioxo-6,12-dioxatetracyclo[9.9.0.0²,⁸.0¹³,¹⁹]icosa-13,16,18-triene-16-carboxylate
1-[9-hydroxy-1,5-dimethyl-5-(4-methylpent-3-en-1-yl)-6,15-dioxatetracyclo[9.3.1.0⁴,¹³.0⁷,¹²]pentadeca-7,9,11-trien-8-yl]-3-phenylprop-2-en-1-one
methyl (1s,2r,5r,7r,9r,10s,13r,15s)-7-hydroxy-4,5,7,10,14,14-hexamethyl-6,8,17-trioxo-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadec-3-ene-9-carboxylate
[2-(acetyloxy)-7-ethenyl-4b,10-dihydroxy-1,7-dimethyl-9-oxo-2h,3h,3ah,4h,5h,6h-cyclopropa[f]phenanthren-1-yl]methyl 2-methylpropanoate
(1s,2r,4s,5r,6r,7s,9r)-4,5-bis(acetyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate
4-[7-hydroxy-3,5-dimethyl-6-(pent-3-en-1-yl)-1-benzofuran-4-yl]-3,5-dimethyl-6-(pent-3-en-1-yl)-1-benzofuran-7-ol
(1r,3as,5as,7s,9as,11ar)-9a-formyl-3a,5a-dihydroxy-11a-methyl-1-(6-oxopyran-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate
(1s,2r,5s,6s,7s,9r)-5-(acetyloxy)-6-[(acetyloxy)methyl]-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate
3-{[2,4-dihydroxy-6-methoxy-5-(3-methylbut-2-en-1-yl)-3-[(2r)-2-methylbutanoyl]phenyl]methyl}-6-ethyl-4-hydroxy-5-methylpyran-2-one
3-[(1e,6z)-8-hydroxyocta-1,6-dien-1-yl]-4-[(2s)-2-(4-methyl-2,5-dioxofuran-3-yl)nonyl]furan-2,5-dione
2,10-bis(acetyloxy)-4,14,15,15-tetramethyl-8-methylidene-13-oxotetracyclo[9.3.1.0¹,⁹.0⁴,⁹]pentadec-6-en-3-yl acetate
methyl (1r,3s,3ar,8as)-1-(2-methoxy-2-oxoethyl)-3a-methyl-3-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3,4,5,8,8a-hexahydro-1h-azulene-6-carboxylate
(5s)-2-{[(5s)-9-hydroxy-3,5-dimethyl-5h,6h,7h,8h-naphtho[2,3-b]furan-4-yl]methyl}-3,4,5-trimethyl-5h,6h,7h,8h-naphtho[2,3-b]furan-9-ol
methyl 6-{3-[(3,3-dimethyloxiran-2-yl)methoxy]-4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-3-(hydroxymethyl)-2-(methoxymethylidene)hexa-3,5-dienoate
(1s,2r,3r,6e,7s,8r,9s,10s)-6-ethylidene-3,9,13-trihydroxy-8-isopropyl-11,20-dimethyl-4-oxa-11,20-diazapentacyclo[8.7.3.0¹,¹⁰.0²,⁷.0¹²,¹⁷]icosa-12,14,16-triene-2-carboxylic acid
2-(5-isopropyl-2-methylphenoxy)-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxane-3,4,5-triol
(1r,2s,7r,10s,11r,16s)-14,16-dihydroxy-7,11-dimethyl-6-(6-oxopyran-3-yl)-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadecan-5-yl acetate
(1r,2s,4r,5s,6r,7r,10s,11r,14s,16s)-14,16-dihydroxy-7,11-dimethyl-6-(6-oxopyran-3-yl)-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadecan-5-yl acetate
(2z,6z)-2-[(3r)-3-chloro-4-methylpent-4-en-1-yl]-9-[(2r)-6-hydroxy-2,8-dimethylchromen-2-yl]-6-methylnona-2,6-dienoic acid
C27H35ClO4 (458.22237400000006)